Compare KOF & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOF | PHG |
|---|---|---|
| Founded | 1979 | 1891 |
| Country | Mexico | Netherlands |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical Electronics |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1B | 23.7B |
| IPO Year | 1998 | 1994 |
| Metric | KOF | PHG |
|---|---|---|
| Price | $118.15 | $26.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | ★ $121.21 | $32.02 |
| AVG Volume (30 Days) | 158.3K | ★ 1.1M |
| Earning Date | 10-26-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.54% | 3.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.44 | $0.52 |
| Revenue Next Year | $7.98 | $4.52 |
| P/E Ratio | ★ $18.35 | $28.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $84.93 | $23.62 |
| 52 Week High | $122.14 | $33.44 |
| Indicator | KOF | PHG |
|---|---|---|
| Relative Strength Index (RSI) | 63.44 | 71.22 |
| Support Level | $103.40 | $26.16 |
| Resistance Level | N/A | $27.49 |
| Average True Range (ATR) | 2.98 | 0.39 |
| MACD | 0.67 | 0.32 |
| Stochastic Oscillator | 73.02 | 97.24 |
Coca-Cola Femsa, a subsidiary of Femsa, is the largest franchise bottler of Coca-Cola in volume terms. The company purchases beverage concentrates and syrup from Coca-Cola, which it then processes and packages for distribution through modern trade, traditional trade, and the on-premises channel. Mexico and Brazil make up 80% of the total volume and sales, with the rest from other Central and South American countries, including Panama, Guatemala, Uruguay, and Argentina. Femsa and Coca-Cola hold 47% and 28% economic interests in Coca-Cola Femsa through nonpublicly traded A and D shares, respectively, while controlling 56% and 33% of the voting power.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.